Sign In
Buy GH
$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
Next Generation Cancer Diagnostics: Technologies and Global Markets (2019-2025) - ResearchAndMarkets.com
12:00am, Tuesday, 25'th Aug 2020
The
Amalgamated Bank Raises Position in Guardant Health Inc (NASDAQ:GH)
08:12am, Monday, 24'th Aug 2020
Amalgamated Bank raised its stake in Guardant Health Inc (NASDAQ:GH) by 59.9% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 15,407 shares of the company’s stock after buying an add
Guardant Health (GH) Investor Presentation - Slideshow
01:41pm, Monday, 17'th Aug 2020
The following slide deck was published by Guardant Health, Inc. in conjunction with this event..
SoftBank Moves Into Asset Management After Return to Profits
10:40am, Tuesday, 11'th Aug 2020
(Bloomberg) -- Masayoshi Son is launching a new asset management venture to buy stocks in publicly traded companies, expanding SoftBank Group Corp.’s investment efforts as it rebounded from record l
If You Had Bought Guardant Health's (NASDAQ:GH) Shares A Year Ago You Would Be Down 13%
05:24pm, Monday, 10'th Aug 2020
Investors can approximate the average market return by buying an index fund. But if you buy individual stocks, you can...
Guardant Health to Participate in Upcoming August Investor Conferences
12:05pm, Monday, 10'th Aug 2020
REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the following investor virtual conferences. * UBS Gen
Industry Ventures Closes $180 Million Direct Venture Fund
12:00am, Monday, 10'th Aug 2020
Industry Ventures, LLC (“Industry Ventures”), a leading investment firm focused on the venture capital market, announced today the final closing of In
Now FDA approved, the Guardant360 CDx delivers critical genomic information to oncologists from a simple blood drawREDWOOD CITY, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasda
What's Behind Guardant Health's Mixed Q2 Results | The Motley Fool
10:42am, Friday, 07'th Aug 2020
The liquid biopsy company beat revenue estimates in Q2, but its bottom line fell short of expectations.
Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates
12:30am, Friday, 07'th Aug 2020
Guardant Health (GH) delivered earnings and revenue surprises of -42.50% and 10.86%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Son’s SoftBank Poised to Return to Profit After Big Losses
10:07pm, Thursday, 06'th Aug 2020
(Bloomberg) -- After reporting record losses in May and warning the coronavirus outbreak could be as devastating as the Great Depression, SoftBank Group Corp. founder Masayoshi Son is already poised t
Guardant Health Reports Second Quarter 2020 Financial Results
08:03pm, Thursday, 06'th Aug 2020
Q2 2020 Revenue Increase of 23% Over Prior Year PeriodREDWOOD CITY, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helpin
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Guardant Health Inc (NASDAQ:GH) Shares Sold by Sumitomo Mitsui Trust Holdings Inc.
06:42am, Tuesday, 04'th Aug 2020
Sumitomo Mitsui Trust Holdings Inc. lowered its position in shares of Guardant Health Inc (NASDAQ:GH) by 31.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The
3 Healthcare Stocks That Could Make You Rich | The Motley Fool
10:46am, Sunday, 02'nd Aug 2020
All three offer innovative technology that meets major healthcare needs.
